$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
疗效显著:塞利尼索显著改善晚期或复发性子宫内膜癌的无进展生存期
2025-10-19 11:44:20
Check Details
度伐利尤单抗(Imfinzi)的中文说明书
2025-10-19 11:44:20
Check Details
治疗鼻咽癌的低毒性选择:奈达铂化疗
2025-10-19 11:44:20
Check Details
FDA批准阿维鲁单抗(Avelumab)用于转移性默克尔细胞癌、晚期或转移性尿路上皮癌以及与阿西替尼联合用于晚期肾细胞癌的治疗
2025-10-19 11:44:20
Check Details
阿维鲁单抗(Avelumab)用法用量:推荐剂量,剂量调整、不良反应剂量调整
2025-10-19 11:44:20
Check Details
阿维鲁单抗(Avelumab)的不良反应和副作用
2025-10-19 11:44:20
Check Details
阿维鲁单抗(Avelumab)详细说明书
2025-10-19 11:44:20
Check Details
阿维鲁单抗(Avelumab)中文说明书:适应症、用法用量、不良反应、注意事项
2025-10-19 11:44:20
Check Details
达拉非尼联合曲美替尼对胶质瘤亚型有良好疗效
2025-10-19 11:44:20
Check Details
靶向药物艾伏尼布治疗胶质瘤疗效强劲
2025-10-19 11:44:20
Check Details
达拉非尼联合曲美替尼治疗BRAF V600E突变型胶质瘤具有持久的临床受益
2025-10-19 11:44:20
Check Details
berubicin获批加速通道指定!多形性胶质母细胞瘤迎来新疗法
2025-10-19 11:44:20
Check Details
1
2
...
6077
6078
6079
6080
6081
6082
6083
...
10214
10215
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Niraparib: A PARP Inhibitor for Ovarian Cancer Maintenance Therapy
2
Abiraterone Acetate: CYP17 Inhibitor for Advanced Prostate Cancer
3
Plerixafor: Mobilizing Hematopoietic Stem Cells for Autologous Transplantation
4
Brensoctib: Managing Side Effects of the Novel DPP-1 Inhibitor for Bronchiectasis
5
Tivozanib: The Evolution of Highly Selective VEGFR Inhibition in Renal Cell Carcinoma
6
Trifluridine/Tipiracil: Managing Side Effects in Metastatic Colorectal and Gastric Cancer
7
Trelagliptin: The First Once-Weekly DPP-4 Inhibitor Revolutionizing Type 2 Diabetes Care
8
Adagrasib Medication Management Guide for Special Populations
9
Olutasidenib (Rezlidhia): A Targeted Drug for IDH1-Mutated Relapsed/Refractory AML
10
Capmatinib Redefines Precision Therapy for MET-Mutated Lung Cancer
11
FDA Approves Dual Immunotherapy Combo: Tecvayli + Darzalex Faspro Transforms RRMM Treatment
12
Cabozantinib: Pivotal Advancements and Global Implications in Multi-Cancer Treatment with Multi-Kinase Inhibition